A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Melanoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
James Graham Brown Cancer Center-University of Louisville, Louisville, Kentucky, United States
Study leads
Jason A Chesney, MD PhD
Principal Investigator
James Graham Brown Cancer Center-U of Louisville